Patient Advocates Raise Alarm Over Republican Proposal to Nix Healthcare Charity Tax Deductions
Premium
The proposal, purported to save $83 billion over a decade, is a "dagger in the heart of all patient advocacy nonprofits," said the head of a cancer patient support group.
At Some Hospitals, Expert Panels Help Guide Anti-Amyloid Drug Decisions for Alzheimer's Patients
Premium
These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such programs are necessary.
FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu in HER2-Ultralow Breast Cancer
The agency approved the drug based on data from the DESTINY-Breast06 trial, which included patients who had tumors with very low HER2 expression.
Fractyl Health Expects to Launch Clinical Trial of Type 2 Diabetes Gene Therapy in 2025
While the company is prioritizing RJVA-001 and a lead program in obesity, it's pausing some R&D efforts and laying off 17 percent of its workforce.
Genetic Testing Challenges in Precision Medicine: Delayed Cascade Testing Due to Unclear Counseling
A patient found to carry a BRCA1 pathogenic variant is not referred to a certified genetic counselor in her health system.
Merck Talks Up Pipeline Diversification as Demand for Keytruda, Facing Patent Expirations, Grows
Premium
The company's blockbuster drug Keytruda contributed $29.48 billion in sales in 2024, but the first of its patent expirations begins in 2028.